Clinical Trials Logo

Clinical Trial Summary

To compare the single-dose bioavailability of Clonazepam ODT 1 mg and Klonopin Wafers 1 mg ODT


Clinical Trial Description

To compare the single -dose bioavailability of kali's Clonazepam ODT 1 mg with that of Klonopin Wafers 1 mg ODT by Roche pharmaceuticals following a single oral dose under fasting conditions. ;


Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label


Related Conditions & MeSH terms

  • Disease
  • To Determine Bioequivalence Under Fasting Conditions

NCT number NCT00652912
Study type Interventional
Source Par Pharmaceutical, Inc.
Contact
Status Completed
Phase Phase 1
Start date March 2004
Completion date May 2004

See also
  Status Clinical Trial Phase
Completed NCT00653380 - Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting Conditions Phase 1
Completed NCT00653120 - Bioavailability Study of Propranolol Under Fasting Conditions Phase 2
Completed NCT00653315 - Bioavailability Study of Tramadol/APAP Tablets Under Fasting Conditions Phase 1
Completed NCT00653419 - Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting Conditions Phase 1
Completed NCT00652795 - Bioequivalence Study Doxycycline Tablets and Monodox Capsules Under Fasting Conditions Phase 1
Completed NCT01380457 - Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting Conditions Phase 1
Completed NCT01380483 - Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fasting Conditions Phase 1
Completed NCT00652639 - Bioavailability Study of Clonazepam Tablets Under Fasting Conditions Phase 1
Completed NCT00653055 - Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fasting Conditions Phase 1
Completed NCT00653549 - Bioavailability Study of Torsemide Tablets Under Fasting Conditions Phase 1